Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Company details
The University of Western Ontario - Industry Liaison
Industry Liaison is the technology transfer office of The University of Western Ontario
The company in detail
Profile
The University of Western Ontario is dedicated to the advancement of learning through teaching and research and to the discovery and application of knowledge. With annual research expenditures of nearly $225 million between the University and its affiliated research institutes, Western ranks as one of the top ten research-intensive universities in Canada. In the fiscal year of 2006, the Western community disclosed 84 inventions, filed 48 US patents, established 25 new commercial licenses and options, and generated $4.8 million in licensing revenue.
Industry Liaison (IL) is the technology transfer office of the university. With a local and global perspective, Industry Liaison strives to provide quality service to develop Western's discoveries and establish a bridge with industry.
A key contributor to Western’s research excellence is Robarts Research Institute, a dedicated medical research centre within the Schulich School of Medicine & Dentistry. Focused on the improved detection and treatment of debilitating disease, Robarts boasts 43 principal investigators (a quarter of whom are practicing clinicians) and a powerful suite of core research facilities – from DNA sequencing and flow cytometry resources to ultra-high field imaging equipment and expertise. Formerly Canada’s largest privately-funded medical research facility, Robarts has recently entered the public sector as an independent research unit of the University, allowing for increased collaboration and excellence in medical research.
In addition, Western is a member of C4, a coalition of eleven universities and research institutions. C4 fosters innovation in south-western Ontario by promoting technology transfer and commercialization. C4 members coordinate their resources, cooperate with governmental and industrial bodies, collaborate in multi-disciplinary research to solve real world problems, and commercialize the results of their research.
The C4 includes the following research institutions in South Western Ontario: McMaster University, University of Guelph, University of Waterloo, Wilfrid Laurier University, University of Windsor, Brock University, Robarts Research Institute, Lawson Health Research Institute, Hamilton Health Sciences, and St. Joseph's Healthcare.
Partnering strategy/interests
Industry Liaison is seeking commercial partners to license university technologies or to establish research collaborations.
Out-licensing
A suite of highly specific, proprietary bacterial drug targets in staphylococcus aureus, that can be used individually or as a group to develop small molecule or peptide drug leads with powerful anti-infectives properties. More
Researchers at the University of Western Ontario have developed a Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More
A non-transgenic, adult onset rodent model for Alzheimer's disease and stroke. More
Western researchers have developed a novel technique, Swallowing Air-Pulse Therapy (SWAPT) and an associated device Swallowing Air-Pulse Therapy System (SWAPTS). More
Identification and use of RAR antagonists to induce bone and cartilage formation More
Suite of proprietary collagen-binding peptides derived from bone sialoprotein (BSP) that are effective in promoting bone repair and regeneration. More
The present invention relates to osteoarthritis (OA) and methods of OA diagnosis and treatment via the findings of a genome-wide analysis of dysregulated genes in OA. More
A number of select phospho-peptides that are derived from the crystal-inhibiting protein osteopontin and that have a distinct set of structural criteria. More
A novel cyclized histatin-based peptide DB2-121 that is a potent new antifungal agent active against the clinically important Candida albicans and a number of other organisms. More
A highly metastatic murine breast cancer cell line that provides an excellent mouse model for fundamental as well as therapeutic studies of human breast cancer metastasis. More
Two isolate Chinese hamster cell lines useful in screening for chemotherapeutic drugs targeting the pathways. More
Western inventors have identified a group of 12 differentially expressed proteins in Preeclampsia (PE) patients using a state-of-art proteomics based approach. More
A flexible, portable, versatile handheld platform that will be useful for a variety of Audiology and Speech Language Pathology applications. More
A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More
This algorithm is used with existing technology to rapidly optimize cancer radiation therapy treatment plans. Also, it has the potential to revolutionize radiation therapy by serving as the platform for adaptive radiation therapy. More
A non-invasive development of a test for the diagnosis and monitoring of endometriosis. More
A novel drug target and peptide(s) designed to inhibit protein synthesis by specifically preventing formation of the 43S preinitiation complex More
A non-pathogenic strain of Burkholderia cepacia provides an opportunity to develop a live vaccine to prevent Bcc infection in CF and critically ill patients, which would dramatically improve the quality of life and life expectancy of these patients. More
A novel mutagenesis system that enables the creation of unmarked and targeted deletions in Burkholderia strains. More
A renowned cardiologist and Robarts' Scientist has identified a strong correlation between a polymorphism of a relatively new apolipoprotein gene and severity of hypertiglyceridemia manifestation. More
A leading ALS scientist at Robarts has identified a biomarker that is sensitive and specific to ALS. More
The present invention relates to methods comprising of specialized mononuclear cells from bone marrow that can rescue hyperglycemia and augment pancreatic repair. More
A Robarts' Scientist has identified a target molecule that can serve as a switch between scar establishment and regenerative matrix deposition by astroctye cells. More
A Robarts' Scientist has generated a target-based primary in vitro cell-based screen for evaluating compounds or peptides affecting scar matrix deposition and remodeling during wound repair. More
A diagnostic and therapeutic secreted target protein that is upregulated in a subset of human patients with Osteoarthritis. It is a strong regulatory candidate for the transformation of maintenance chondrocytes into digestive aggravators of OA. More
A powerful technology for the simultaneous monitoring of protein kinase activities in cell and tissue extracts using a multiplexed electrochemical assay More
An innovative, real-time test of oocyte quality, applicable to assisted conception treatments, that does no harm to the oocyte itself. More
Press Releases
(11th Jul 2008) Researchers at Robarts Research Institute at The University of Western Ontario have found clear evidence that increases in the size of the brain ventricles are directly associated with cognitive impairment and Alzheimer's disease. More
(12th Jun 2008) Two new research chairs named, three renewed More
(21st May 2008) Six Western projects are one step closer to moving their work towards commercialization with awards from the Western Innovation Fund. More
(14th May 2008) John MacDonald has been named the new Scientific Director for Robarts Research Institute at The University of Western Ontario More
(7th May 2008) More Than $10 Million for Leading Health Research at City Institutions More
(5th May 2008) WORLDiscoveriesTM, a new technology transfer consortium formed by London's research institutions, will develop small- and medium-sized enterprises in the region, creating 250 jobs and generating $50 million in investment over the next three years. More
(2nd May 2008) Robarts Research Institute scientist Paula Foster and Schulich School of Medicine & Dentistry's David Litchfield will receive more than $885,000 to fund innovative research projects. More
(17th Apr 2008) Wednesday, April 23, 2008 at University Hospital, London, Ontario, Canada More
(14th Apr 2008) Both Aaron Fenster and Patrick Mahon have been named 2008 recipients of The Hellmuth Prize, The University of Western Ontario's highest honour for contributions to research. More
(11th Apr 2008) Dr. Aaron Fenster of Robarts Research Institute will receive the Hellmuth Prize in a public presentation April 14. More
(10th Apr 2008) Join medical students, faculty, health care professionals and community members at the Hungry for Change gala in support of global health education and the Huruma Children's Home in Kenya More
(9th Apr 2008) Parvaz Madadi, BMSc, a graduate student at the Schulich School of Medicine & Dentistry at Western, has been awarded the prestigious 2008 David J. Goldstein Trainee Award by the American Society for Clinical Pharmacology and Therapeutics. More
(9th Apr 2008) An international study led by Brian Feagan of Robarts Research Institute at The University of Western Ontario has found that omega-3 fatty acids are ineffective for managing Crohn's disease. More
(7th Apr 2008) The commercialization of intellectual property at Western has been given a boost with the introduction of the Ontario Tax Exemption for Commercialization (OTEC) program, announced in last week's provincial budget. More
(4th Apr 2008) The 4T facility, located on Robarts' north side between the medical research institute and University Hospital, is currently being remodeled to allow room for two new MRI systems, used to investigate in-vivo studies of brain structure and function. More
(2nd Apr 2008) Robarts Research Institute, (at The University of Western Ontario) London, for Dr. Aaron Fenster's 3-D ultrasound-guided intra-operative and dynamic minimally invasive brachytherapy and biopsy platform More
(31st Mar 2008) Cardiovascular pharmacologist Dr. Robert Gros from Robarts Research Institute links hypertension to the protein GRK-2 More
(27th Mar 2008) The newly funded lab, led by Anatomy & Cell Biology professor Lynne-Marie Postovit at the Schulich School of Medicine & Dentistry, will look at the types of microenvironments that regulate both normal and cancer cell plasticity and function. More
(26th Mar 2008) Public Lecture with Robarts geneticist Dr. Robert Hegele, March 27, 2008 More
(20th Mar 2008) John M. Thompson, chairman of the board of TD Bank Financial Group, has been named 20th chancellor of The University of Western Ontario. More
(13th Mar 2008) Schedule for a full day of events showcasing innovative research at Robarts Research Institute More
(12th Mar 2008) In celebration of his lifetime of giving, Schulich will receive an honorary degree from The University of Western Ontario at its medical convocation on Friday, May 16 at 10 a.m. More
(11th Mar 2008) Sirtris Pharmaceuticals, Inc. obtained exclusive, worldwide rights from Robarts Research Institute for NamPRT (also known as Visfatin), an important genetic driver of cellular stress resistance and longevity in mammals. More
(22nd Feb 2008) An international Robarts research study opens the door to a safer and more effective treatment option for Crohn's disease More
(14th Feb 2008) Assisted by advanced technology, some of the sharpest minds at Western work to solve the mysteries of the brain. More
(7th Feb 2008) Western's Experimental Eye Research Facility brings professionals from different backgrounds together to study the eye. More
(31st Jan 2008) Dr. Stewart Harris, the lead investigator of a study which revealed that half of Canadians with diabetes are not properly controlling their disease, has been selected as the first holder of the CDA Chair in Diabetes Management at Western. More
(29th Jan 2008) Improved techniques to better diagnose diseases such as brain cancer, epilepsy, stroke, and Alzheimer's disease is the goal of new research in London funded by the McGuinty government. More
(16th Jan 2008) Healthcare students from across Canada will learn the value of team work to improve patient safety at the fourth annual National Interprofessional Healthcare Conference at the Hilton Hotel in London January 19-20, 2008. More
(7th Jan 2008) Support Tim Liddiard and Francis Chan in taking action in the fight against prostate cancer…. More
(20th Dec 2007) The Schulich School of Medicine & Dentistry at The University of Western Ontario has announced David Holdsworth as the first holder of the Dr. Sandy Kirkley Chair in Musculoskeletal Research. More
(19th Dec 2007) Schulich School of Medicine & Dentistry to offer lecture, January 9, 7-8 p.m. in Sifton Room, Masonville Library. More
(10th Dec 2007) Elderly patients who undergo hip and knee replacement surgery experience less pain and require 80 per cent less narcotics as a result of a newly developed drug combination administered before, during, and after surgery More
(29th Nov 2007) Dean Carol Herbert discusses progress in the integration of Schulich and Robarts at the University of Western Ontario More
(20th Nov 2007) Western celebrates its medical and dental exchange program with Belarus. More
(19th Nov 2007) The University's latest ad campaign promotes an impressive research portfolio More
(13th Nov 2007) Dr. Rory Collins headlines the Taylor Prize Symposium at the University of Western Ontario. More
(7th Nov 2007) Western graduate students and post-doctoral fellows to present on infection and immunity this Nov 16, 2007 More
(5th Nov 2007) Scientists at Robarts Research Institute have developed a simplified and more effective method of treating high blood pressure. More
(9th Oct 2007) Scientists at Robarts Research Institute and The University of Western Ontario find marker for addressing infection in patients undergoing peritoneal dialysis. More
(7th Sep 2007) Rogers Television First Local ran a six-part series over the summer, clips are now available online. More
Head office
The University of Western Ontario - Industry Liaison
Gordon Mogenson Building, Suite 105
100 Collip Circle
The University of Western Ontario Research Park
London
Ontario
N6G 4X8
Ontario
Tel: +1 519 661 4152
www | email
Gordon Mogenson Building, Suite 105
100 Collip Circle
The University of Western Ontario Research Park
London
Ontario
N6G 4X8
Ontario
Tel: +1 519 661 4152
www | email
Contact details
Dr. Susanne Acklin
Industry Liaison Officer
Industry Liaison, Research Western
Industry Liaison Officer
Industry Liaison, Research Western
Sunita Asrani
Industry Liaison Officer, Health Science
McMaster Office of Research Contracts
Request more information
Industry Liaison Officer, Health Science
McMaster Office of Research Contracts
Request more information
Patrick Therrien
Technology Transfer & BDO
Industry Liaison for Faculty of Science
Request more information
Technology Transfer & BDO
Industry Liaison for Faculty of Science
Request more information
Company figures
Formed: 1996
Annual Turnover: $544,000 (licensing) (2007)
Number of employees: 12
Annual Turnover: $544,000 (licensing) (2007)
Number of employees: 12
Related categories
- Industry sector
- Biotech
- Medical device
- Diagnostic
- Pharmaceutical
- Drug delivery
- Biotechnology / Human diagnostics
- Biotechnology / Stem cells
- Biotechnology / Gene therapy
- Biotechnology / Research supplies
- Biotechnology / Assay systems
- Biotechnology / Human therapeutics
- Biotechnology / Nanotechnology
- Biotechnology / Diagnostic test systems
- Diagnostic / Genetic diagnostics
- Medical device / Therapeutic device
- Research tools / Cell lines
- Research tools / Mouse models
- Research tools / Biomarkers
- Therapeutic target
- Accident and Trauma
- Accident and Trauma / Stroke/traumatic brain injury
- Cardiovascular
- Central Nervous System / Neurodegenerative disorders
- Central Nervous System / Neurological
- Central Nervous System / Traumatic brain injury
- Genito-urinary
- Immune related disorders
- Musculoskeletal
- Musculoskeletal / Skeletal / Osteoarthritis
- Oncology
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us